Oral pharmaceutical composition containing cyclosporin and proce

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 11, A61K 3700, A61K 3174, A61K 3800

Patent

active

054300177

ABSTRACT:
The invention relates to a pharmaceutical composition for oral administration containing cyclosporin A and/or cyclosporin G as active ingredient, which possess advantageous absorption characteristics, and to a process for preparing this composition. The composition according to the invention comprises 1 part by mass of one or more cyclosporin(s) dissolved in 4 to 50 parts by volume of propylene glycol, 0 to 25 parts by volume of ethanol and 0.0 to 5 parts by mass of a polyoxyethylene/polyoxypropylene block polymer in homogenized state. Based on examinations carried out at 100.degree. C., the stability of solutions prepared according to the invention does not differ from that of the commercially available Sandimmun oral solution.

REFERENCES:
patent: 4649047 (1987-03-01), Kagwari
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5051402 (1991-09-01), Kurihara et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oral pharmaceutical composition containing cyclosporin and proce does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral pharmaceutical composition containing cyclosporin and proce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral pharmaceutical composition containing cyclosporin and proce will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-760090

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.